![John Rothman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Rothman
Teknisk/Vetenskaplig/F&U Direktör på
RIZE ONCOLOGY INC.
Förmögenhet: 14 470 $ per 2025-04-30
Profil
John M.
Rothman is Chief Scientific Officer at Rize Oncology, Inc. since 2025.
Former positions include Senior Director at Schering-Plough Canada, Inc., EVP-Clinical & Scientific Operations at Advaxis, Inc. from 2011 to 2013, Chief Scientific Officer at Racura Oncology Ltd., and Executive Vice President-Product Development at Tyme Technologies, Inc. from 2020 to 2022.
Education includes a doctorate from Tulane University School of Medicine.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
RIZE ONCOLOGY INC. 1,32 % | 2025-01-06 | 1 000 000 ( 1,32 % ) | 14 470 $ | 2025-04-30 |
Aktiva positioner av John Rothman
| Företag | Position | Start |
|---|---|---|
| RIZE ONCOLOGY INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-01-09 |
Tidigare kända positioner av John Rothman
| Företag | Position | Slut |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Företagsledare/Principal | 2022-02-01 |
| RACURA ONCOLOGY LTD | Teknisk/Vetenskaplig/F&U Direktör | 2019-10-01 |
| AYALA PHARMACEUTICALS, INC. | Verksamhetschef | 2011-12-09 |
Schering-Plough Canada, Inc.
 Schering-Plough Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Direktör/Styrelseledamot | - |
John Rothmans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
24
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
Schering-Plough Canada, Inc.
Schering-Plough Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Health Technology |
Tulane University School of Medicine
 Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
GeneTether Therapeutics, Inc.
 GeneTether Therapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapies and platform | Health Technology |
